Johannes M. Schmid
Palle Juul Jensens Boulevard 99
Aarhus N, 8200, Denmark
Aarhus N, 8200, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Efficacy and Safety of Intralymphatic Immunotherapy With Grass Allergoid and Microcrystalline Tyrosine: A Double-Blind Randomised Placebo-Controlled Trial.
Journal: Allergy
Published: March 13, 2026
Five-year inhaled, systemic, and total corticosteroid exposure reduction during anti‒interleukin-5 receptor alpha treatment for severe asthma.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: January 21, 2026
Adult reference values for spirometry, body plethysmography and diffusing capacity adjusted for sex, age, weight, height or arm span - the Danish lung function material (DALFUMAT) study.
Journal: European clinical respiratory journal
Published: January 09, 2026
From mild-to-moderate to severe asthma: risk factors and patient profiles from the NORDSTAR cohort.
Journal: American journal of respiratory and critical care medicine
Published: November 24, 2025
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysis.
Journal: BMJ open respiratory research
Published: October 14, 2025
Acceptability and feasibility of a need-supportive intervention to increase trial retention: a randomised feasibility study within a randomised controlled allergy trial in Denmark.
Journal: BMJ open
Published: September 15, 2025
Low-Dose Intralymphatic Immunotherapy for Grass Pollen Allergy is Both Safe and Effective.
Journal: Allergy
Published: September 06, 2025
Financial burden of productivity loss in severe asthma and impact of biologic therapy.
Journal: Pulmonology
Published: July 21, 2025
Identifying an At-Risk Asthma Phenotype: Allergy and Recurrent Infections Predict Severe Disease.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: July 07, 2025
Study protocol: a 52-week, multicentre, observational, prospective study on the use of a smart platform connected to a single-inhaler triple therapy (ICS/LABA/LAMA) to evaluate effectiveness on treatment adherence and inhaler technique in patients with poorly controlled asthma.
Journal: BMC pulmonary medicine
Published: June 10, 2025
Cumulative corticosteroid burden over 25 years in patients initiating biologic therapy for severe asthma: a nationwide cohort study.
Journal: ERJ open research
Published: May 29, 2025
Last Updated: 09/26/2026